Search Within

Elaina Vitale Preston

Formats
  1. Meeting Abstract (8)
  2. Journal Article (4)
Groups
  1. Advanced Practice Providers (12)
  2. Bone Marrow Transplant (12)
  3. Center for Hematologic Malignancies (12)
  4. Department of Medicine (12)
  5. Hematologic Malignancies, Division of (12)
  6. Survivorship Research (12)

More Groups

People
  1. Gunjan Shah (10)
  2. Sergio Giralt (10)
  3. Sean Devlin (9)
  4. Miguel-Angel Perales (7)
  5. Michael Scordo (5)
  6. Molly Maloy (5)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2022 (2)
  4. 2019 (1)
  5. 2018 (6)
  6. 2017 (1)
Publications
  1. Biology of Blood and Marrow Transplantation (5)
  2. Blood (4)
  3. American Journal of Hematology (1)
  4. Bone Marrow Transplantation (1)
  5. Cancer (1)
Publishers
  1. Elsevier Inc. (5)
  2. American Society of Hematology (4)
  3. John Wiley & Sons, Inc. (1)
  4. Nature Publishing Group (1)
  5. Wiley Blackwell (1)

Results (12)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantation
    Journal Article

    Melica, G.; Preston, E.; Palazzo, M.; Seier, K.; Malard, F.; Cho, C.; Devlin, S. M.; Maloy, M.; Borrill, T.; Maslak, P.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemia
    Journal Article

    Nath, K.; Lee, J.; Elko, T. A.; Levy, L.; Preston, E.; Devlin, S. M.; Ponce, D. M.; Lin, R. J.; Shaffer, B. C.; Cho, C.; more...
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with newly diagnosed and relapsed acute leukemia
    Meeting Abstract

    Nath, K.; Lee, J.; Elko, T. A.; Levy, L.; Preston, E.; Devlin, S. M.; Ponce, D. M.; Lin, R. J.; Shaffer, B. C.; Cho, C.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • A prospective study of dysgeusia and related symptoms in patients with multiple myeloma after autologous hematopoietic cell transplantation
    Journal Article

    Scordo, M.; Shah, G. L.; Adintori, P. A.; Knezevic, A.; Devlin, S. M.; Buchan, M. L.; Preston, E. V.; Lin, A. P.; Rodriguez, N. T.; Carino, C. A.; more...
    Cancer (2022)

    Fulltext@MSK | Save
  • Efficacy of revaccination after autologous hematopoietic stem cell transplantation in lymphoma patients with or without rituximab exposure
    Meeting Abstract

    Preston, E. V.; Palazzo, M.; Seier, K.; Maloy, M. A.; Devlin, S. M.; Giralt, S. A.; Scordo, M.; Dahi, P. B.; Matasar, M. J.; Moskowitz, C. H.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Dysgeusia is associated with higher melphalan pharmacokinetic levels and results in poorer caloric intake and worse symptom burden after autologous stem cell transplantation for multiple myeloma
    Meeting Abstract

    Scordo, M.; Shah, G. L.; Preston, E. V.; Rodriguez, N.; Lin, A.; Maloy, M.; Mastrogiacomo, B.; Carlow, D.; Schofield, R.; Knezevic, A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Impact of pre-transplant rituximab on efficacy of revaccination of lymphoma patients after autologous hematopoietic stem cell transplantation
    Meeting Abstract

    Preston, E. V.; Palazzo, M. A.; Seier, K.; Devlin, S. M.; Giralt, S.; Scordo, M.; Dahi, P. B.; Matasar, M. J.; Moskowitz, C. H.; Sauter, C. S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Unlocking the complex flavors of dysgeusia after hematopoietic cell transplantation
    Journal Article

    Scordo, M.; Shah, G. L.; Peled, J. U.; Preston, E. V.; Buchan, M. L.; Epstein, J. B.; Barasch, A.; Giralt, S. A.
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Disease progression is main barrier to allogeneic hematopoietic stem cell transplantation (HCT) in patients with newly diagnosed and relapsed acute leukemia
    Meeting Abstract

    Preston, E. V.; Chinapen, S.; Borrill, T.; Davis, E.; Shaffer, B. C.; Tamari, R.; Jakubowski, A. A.; Perales, M. A.; Ponce, D. M.; Shah, G. L.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Rituximab use, immune reconstitution, and vaccination after ex-vivo CD34-selected myeloablative allogeneic hematopoietic cell transplantation (HCT)
    Meeting Abstract

    Preston, E. V.; Malard, F.; Seier, K.; Cho, C.; Devlin, S. M.; Maloy, M.; Borrill, T.; Palazzo, M.; Smith, K.; Maslak, P.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save